Evidence map›Paper›PMID 37644959›Full record

ArticleDEN open2024

Effect of COVID-19 infection on the gastrointestinal tract considering preventive methods during endoscopic procedures.

Sakiko Naito, Itaru Nakamura, Tomohiro Umezu, Akihiro Hata, Akira Madarame, Kumiko Uchida, Yohei Koyama, Takashi Morise, Hayato Yamaguchi, Shin Kono and 6 more

Open access · goldAbstract read
In one paragraph

Article in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Sakiko NaitoDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-7533-1061
Itaru NakamuraDepartment of Infection Control and Prevention Tokyo Medical University Tokyo Japan.
Tomohiro UmezuDepartment of Molecular Pathology Tokyo Medical University Tokyo Japan.
Akihiro HataDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Akira MadarameDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Kumiko UchidaDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Yohei KoyamaDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0003-2511-2722
Takashi MoriseDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Hayato YamaguchiDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-5208-554X
Shin KonoDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Mitsushige SugimotoDepartment of Gastroenterological Endoscopy Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-9194-7392
Takashi KawaiDepartment of Gastroenterological Endoscopy Tokyo Medical University Tokyo Japan.
Yuichiro HaradaDepartment of Molecular Pathology Tokyo Medical University Tokyo Japan.
Masahiko KurodaDepartment of Molecular Pathology Tokyo Medical University Tokyo Japan.
Masakatsu FukuzawaDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.
Takao ItoiDepartment of Gastroenterology and Hepatology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-9433-8437
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study aimed to prevent the infection risk of environmental contamination by feces during endoscopic procedures. We evaluated the effect of coronavirus disease 2019 (COVID-19) on the gastrointestinal tract using fecal polymerase chain reaction (PCR) and examined risk factors affecting endoscopic procedures, to develop infection prevention strategies. Methods: This single-center prospective observational study enrolled 32 patients diagnosed with COVID-19 at Tokyo Medical University Hospital between January and December 2022. We performed reverse transcriptase-PCR to detect severe acute respiratory syndrome coronavirus 2 in human stool specimens and evaluated the COVID-19 positivity rate in stool, the effect of vaccination on infection detection, and differences in positivity rates considering different patient backgrounds. Results: Among the 32 nasal PCR-positive patients who underwent fecal PCR testing, the fecal PCR positivity rate was 21.8%. Compared to the negative cases, 71.4% vs. 32% were older than 65 years ( Conclusions: The severe acute respiratory syndrome coronavirus 2 affects not only the upper respiratory tract but also the gastrointestinal tract. These findings may indicate the risk of digestive fluid infection in older patients with gastrointestinal symptoms and immunocompromised patients with malignant tumor comorbidities, especially during the early stages of viral infection. Therefore, it is advisable to establish a system to prevent infection by using personal protective equipment, including eye guards, in future endoscopic procedures.

Indexed as

COVID‐19digestive fluid infectionendoscopyfecal PCRgastrointestinal tract

Identifiers

PMID37644959
PMCPMC10461040
OpenAlexW4386225486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.